Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates

Journal of Microbiological Methods

Volumn 57, Issue 3, 2004, Pages 323-335

  Mokrousov, Igor ^a   Bhanu, N Vijaya ^b   Suffys, Philip N ^c   Kadival, Gururaj V ^d   Yap, Sook Fan ^e   Cho, Sang Nae ^f   Jordaan, Annemarie M ^g   Narvskaya, Olga ^a   Singh, Urvashi B ^b   Gomes, Harrison M ^c   Lee, Hyeyoung ^h   Kulkarni, Savita P ^d   Lim, Kuo Chieh ^e   Khan, Baldip K ⁱ   Van Soolingen, Dick ^j   Victor, Thomas C ^g   Schouls, Leo M ^j  

^a ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d BHABHA ATOMIC RESEARCH CENTRE   (India)

^e UNIVERSITY OF MALAYA   (Malaysia)

^f Yonsei University College of Medicine   (South Korea)

^g STELLENBOSCH UNIVERSITY   (South Africa)

^h Yonsei University Wonju   (South Korea)

ⁱ INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^j NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

more..

Author keywords

Drug resistance; Mycobacterium tuberculosis; Reverse hybridization

Indexed keywords

ANTIBIOTIC AGENT; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM MUTANT; CODON; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; EVALUATION; GENE SEQUENCE; GENE TARGETING; GEOGRAPHIC DISTRIBUTION; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; REPRODUCIBILITY; REVERSE LINE BLOT ASSAY; SAMPLE; STRAIN IDENTIFICATION; VALIDATION PROCESS; WILD TYPE;

ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RIFAMPIN; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 2342664096     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2004.02.006     Document Type: Article

References (36)

1. Abadi F.J.R., Carter P.E., Cash P., Hugh Pennington T. Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability. Antimicrob. Agents Chemother. 40:1996;646-651
2. Billington O.J., McHugh T.D., Gillespie S.H. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:1999;1866-1869
3. Cavusoglu C., Hilmioglu S., Guneri S., Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J. Clin. Microbiol. 40:2002;4435-4438
4. Cockerill F.R. III Genetic methods for assessing antimicrobial resistance. Antimicrob. Agents Chemother. 43:1999;199-212
5. De Beenhouwer H., Lhiang Z., Jannes G., Mijs W., Machtelinckx L., Rossau R., Traore H., Portaels F. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber. Lung Dis. 76:1995;425-430
6. Dobner P., Bretzel G., Rüsch-Gerdes S., Feldmann K., Rifai M., Löscher T., Rinder H. Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis. Mol. Cell. Probes. 11:1997;123-126
7. Finken M., Kirschner P., Meier A., Wrede A., Böttger C. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis, alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol. Microbiol. 9:1993;1239-1246
8. Heep M., Beck D., Bayerdorffer E., Lehn N. Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob. Agents Chemother. 43:1999;1497-1499
9. Heep M., Brandstätter B., Rieger U., Lehn N., Richter E., Rusch-Gerdes S., Niemann S. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39:2001;107-110
10. Kamerbeek J., Schouls L., Kolk A., van Agterveld M., van Soolingen D., Kuijper S., Bunschoten A., Molhuizen H., Shaw R., Goyal M., van Embden J.D.A. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:1997;907-914
11. Kelley C.L., Rouse D.A., Morris S.L. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:1997;2057-2058
12. Kiepiela P., Bishop K.S., Smith A.N., Roux L., York D.F. Genomic mutations in the katG, inhA, and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber. Lung Dis. 80:2000;47-56
13. Lee H., Cho S.N., Bang H.E., Lee J.H., Bai G.H., Kim S.J., Kim J.D. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea. Int. J. Tuberc. Lung Dis. 4:2000;441-447
14. Lee A.S.G., Teo A.S.M., Wong S.-Y. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 45:2001;2157-2159
15. Mdluli K., Sherman D.R., Hickey M.J., Kreiswirth B.N., Morris S., Stover C.K., Barry C.E. III Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. J. Infect. Dis. 174:1996;1085-1090
16. Meier A., Sander P., Schaper K.-J., Scholz M., Böttger E.C. Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40:1996;2452-2454
17. Mokrousov I., Otten T., Filipenko M.L., Vyazovaya A., Chrapov E., Limeschenko E., Steklova L., Vyshnevskiy B., Narvskaya O. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by multiplex allele-specific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol. 40:2002;2509-2512
18. Mokrousov I., Otten T., Vyshnevskiy B., Narvskaya O. Detection of embB306 mutations in ethambutol-susceptible Mycobacterium tuberculosis clinical isolates from northwestern Russia, implications for genotypic resistance testing. J. Clin. Microbiol. 40:2002;3810-3813
19. Morcillo N., Zumarraga M., Alito A., Dolmann A., Schouls L., Cataldi A., Kremer K., van Soolingen D. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 6:2002;959-965
20. Pozzi G., Meloni M., Iona E., Orru G., Thoresen O.F., Ricci M.L., Oggioni M.R., Fattorini L., Orefici G. rpoB mutations in multi-drug resistant strains of Mycobacterium tuberculosis isolated in Italy. J. Clin. Microbiol. 37:1999;1197-1199
21. Ramaswamy S.V, Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis, 1998 update. Tuber. Lung Dis. 79:1998;3-29
22. Reynolds M.G. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics. 156:2000;1471-1481
23. Severinov K., Soushko M., Goldfarb A., Nikiforov V. Rifampin region revisited. New rifampin resistant and streptolydigin resistant mutants in the beta subunit of E. coli RNA polymerase. J. Biol. Chem. 268:1993;14820-14825
24. Slayden R.A., Barry C.E. III The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect. 2:2000;659-669
25. Sreevatsan S., Pan X., Stockbauer K., Connell N., Kreiswirth B., Whittam T., Musser J.M. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionary recent global dissemination. Proc. Natl. Acad. Sci. U. S. A. 97:1997;9869-9874
26. Taniguchi H., Aramaki H., Nikaido Y., Mizuguchi Y., Nakamura M., Koga T., Yoshida S. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol. Lett. 144:1996;103-108
27. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S., Colston M.J., Matter L., Schopfer K., Bodmer T. Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis. Lancet. 341:1993;647-650
28. Telenti A., Honore N., Bernasconi C., March J., Ortega A., Heym B., Takiff H.E., Cole S.T. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis, a blind study at reference laboratory level. J. Clin. Microbiol. 35:1997;719-723
29. Telenti A., Philipp W.J., Sreevatsan S., Bernasconi C., Stockbauer K.E., Wieles B., Musser J.M., Jacobs W.R. Jr. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 3:1997;567-570
30. van Embden J.D.A., Cave M.D., Crawford J.T., Dale J.W., Eisenach K.D., Gicquel B., Hermans P., Martin C., McAdam R., Shinnik T.M., Small P. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting, recommendations for a standardized methodology. J. Clin. Microbiol. 31:1993;406-409
31. van Rie A., Warren R., Mshanga I., Jordaan A.M., van der Spuy G.D., Richardson M., Simpson J., Gie R.P., Enarson D.A., Beyers N., van Helden P.D., Victor T.C. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol. 39:2001;636-641
32. Victor T.C., van Rie A., Jordaan A.M., Richardson M., van der Spuy G.D., Beyers N., van Helden P.D., Warren R. Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance. J. Clin. Microbiol. 39:2001;4184-4186
33. Victor T.C., Lee H., Cho S.N., Jordaan A.M., van der Spuy G., van Helden P.D., Warren R. Molecular detection of early appearance of drug resistance during Mycobacterium tuberculosis infection. Clin. Chem. Lab. Med. 40:2002;876-881
34. Victor T.C., van Helden P.D., Warren R. Prediction of drug resistance in M. tuberculosis, molecular mechanisms, tools and applications. IUBMB Life. 53:2002;231-237
35. World Health Organization Anti-tuberculosis drug resistance in the world. 1997;. Geneva
36. Wu X., Zhang J., Zhuang Y., Zhang X., Li G., He X. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates. Chin. Med. J. (Engl.). 112:1999;524-528